$TTPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TETRAPHASE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TETRAPHASE PHARMACEUTICALS INC. Get notifications about new insider transactions in TETRAPHASE PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 22 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 11.59 | 10,000 | 115,900 | 50,000 | 60 K to 50 K (-16.67 %) |
Aug 22 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 10,000 | 8,700 | 60,000 | 50 K to 60 K (+20.00 %) |
Aug 07 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 25,000 | 21,750 | 130,172 | |
Aug 07 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 25,000 | 21,750 | 50,000 | 25 K to 50 K (+100.00 %) |
Jul 22 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 40,000 | 34,800 | 155,172 | |
Jul 22 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 10.61 | 15,000 | 159,102 | 25,000 | 40 K to 25 K (-37.50 %) |
Jul 22 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 40,000 | 34,800 | 40,000 | 0 to 40 K |
Jun 25 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 13.77 | 47,184 | 649,889 | 1,690,146 | 1.7 M to 1.7 M (-2.72 %) |
Jun 23 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 13.65 | 82,716 | 1,128,933 | 1,737,330 | 1.8 M to 1.7 M (-4.54 %) |
Jun 23 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | S | 13.08 | 70,100 | 916,712 | 1,820,046 | 1.9 M to 1.8 M (-3.71 %) |
Jun 19 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 15,000 | 13,050 | 35,849 | |
Jun 19 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 12.28 | 15,000 | 184,226 | 0 | 15 K to 0 (-100.00 %) |
Jun 19 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 15,000 | 13,050 | 15,000 | 0 to 15 K |
Jun 18 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Sell | S | 12.51 | 13,530 | 169,260 | 78,463 | 92 K to 78.5 K (-14.71 %) |
Jun 17 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 11.42 | 500 | 5,710 | 2,825 | 2.3 K to 2.8 K (+21.51 %) |
Jun 17 2014 | TTPH | TETRAPHASE PHARMAC ... | Chodakewitz Jeffrey | Director | Option Exercise | A | 11.44 | 20,000 | 228,800 | 20,000 | |
Jun 16 2014 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 11.26 | 10,000 | 112,600 | 10,000 | |
Jun 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Option Exercise | A | 11.26 | 10,000 | 112,600 | 10,000 | |
Jun 16 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 11.26 | 10,000 | 112,600 | 10,000 | |
Jun 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Gullans Steven R. Ph.D. | Director | Option Exercise | A | 11.26 | 10,000 | 112,600 | 10,000 | |
Jun 05 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 10.05 | 500 | 5,025 | 1,350 | 850 to 1.4 K (+58.82 %) |
Jun 09 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 10.28 | 975 | 10,027 | 2,325 | 1.4 K to 2.3 K (+72.22 %) |
Jun 03 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 10.70 | 850 | 9,095 | 850 | 0 to 850 |
May 21 2014 | TTPH | TETRAPHASE PHARMAC ... | Gullans Steven R. Ph.D. | Director | Buy | P | 9.24 | 25,000 | 230,978 | 25,000 | 0 to 25 K |
May 21 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 15,000 | 13,050 | 50,849 | |
May 21 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 9.00 | 15,000 | 135,000 | 0 | 15 K to 0 (-100.00 %) |
May 21 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 15,000 | 13,050 | 15,000 | 0 to 15 K |
May 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Buy | J | 0.00 | 3,006 | 0 | 3,006 | 0 to 3 K |
May 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | J | 0.00 | 4,493 | 0 | 0 | 4.5 K to 0 (-100.00 %) |
May 16 2014 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Buy | P | 9.25 | 5,000 | 46,249 | 5,000 | 0 to 5 K |
Apr 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 15,000 | 13,050 | 65,849 | |
Apr 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 9.69 | 15,000 | 145,350 | 0 | 15 K to 0 (-100.00 %) |
Apr 16 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 15,000 | 13,050 | 15,000 | 0 to 15 K |
Mar 21 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Sell | S | 12.41 | 11,494 | 142,641 | 17,242 | 28.7 K to 17.2 K (-40.00 %) |
Mar 14 2014 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | J | 0.00 | 4,493 | 0 | 4,493 | 0 to 4.5 K |
Mar 14 2014 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 1,890,146 | 2.2 M to 1.9 M (-13.70 %) |
Mar 14 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Buy | J | 0.00 | 4,493 | 0 | 4,493 | 0 to 4.5 K |
Mar 14 2014 | TTPH | TETRAPHASE PHARMAC ... | Freund John Gordon | Director | Sell | J | 0.00 | 300,000 | 0 | 1,890,146 | 2.2 M to 1.9 M (-13.70 %) |
Mar 12 2014 | TTPH | TETRAPHASE PHARMAC ... | Wysenski Nancy | Director | Option Exercise | A | 12.38 | 20,000 | 247,600 | 20,000 | |
Mar 10 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Sell | S | 13.65 | 4,510 | 61,562 | 91,993 | 96.5 K to 92 K (-4.67 %) |
Feb 24 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Sell | S | 14.00 | 11,494 | 160,916 | 28,736 | 40.2 K to 28.7 K (-28.57 %) |
Feb 13 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Sell | S | 13.92 | 4,506 | 62,724 | 96,503 | 101 K to 96.5 K (-4.46 %) |
Feb 12 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | M | 0.87 | 15,000 | 13,050 | 80,849 | |
Feb 12 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Sell | S | 14.42 | 15,000 | 216,300 | 0 | 15 K to 0 (-100.00 %) |
Feb 12 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Buy | M | 0.87 | 15,000 | 13,050 | 15,000 | 0 to 15 K |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Option Exercise | M | 2.03 | 20,614 | 41,846 | 34,359 | |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Option Exercise | M | 2.03 | 33,295 | 67,589 | 7,684 | |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Option Exercise | M | 0.87 | 34,482 | 29,999 | 0 | |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Sell | S | 14.22 | 9,928 | 141,176 | 101,009 | 110.9 K to 101 K (-8.95 %) |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Buy | M | 2.03 | 20,614 | 41,846 | 110,937 | 90.3 K to 110.9 K (+22.82 %) |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Buy | M | 2.03 | 33,295 | 67,589 | 90,323 | 57 K to 90.3 K (+58.38 %) |
Feb 11 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Buy | M | 0.87 | 34,482 | 29,999 | 57,028 | 22.5 K to 57 K (+152.94 %) |
Feb 07 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Sell | S | 13.93 | 11,494 | 160,111 | 40,230 | 51.7 K to 40.2 K (-22.22 %) |
Feb 05 2014 | TTPH | TETRAPHASE PHARMAC ... | THOMPSON JOHN CRAIG | Chief Operating Off ... | Option Exercise | A | 14.45 | 250,000 | 3,612,500 | 250,000 | |
Jan 29 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Option Exercise | M | 0.87 | 51,724 | 45,000 | 0 | |
Jan 29 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Buy | M | 0.87 | 51,724 | 45,000 | 51,724 | 0 to 51.7 K |
Jan 10 2014 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Option Exercise | A | 14.99 | 100,000 | 1,499,000 | 100,000 | |
Jan 10 2014 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Option Exercise | A | 14.99 | 50,000 | 749,500 | 50,000 | |
Jan 10 2014 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 14.99 | 160,000 | 2,398,400 | 160,000 | |
Jan 10 2014 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 14.99 | 100,000 | 1,499,000 | 100,000 | |
Sep 20 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 10.20 | 2,335 | 23,817 | 47,992 | 50.3 K to 48 K (-4.64 %) |
Sep 20 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 10.20 | 97,665 | 996,183 | 2,007,246 | 2.1 M to 2 M (-4.64 %) |
Sep 18 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 9.48 | 192 | 1,820 | 50,327 | 50.5 K to 50.3 K (-0.38 %) |
Sep 18 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 9.22 | 1,057 | 9,746 | 50,519 | 51.6 K to 50.5 K (-2.05 %) |
Sep 18 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 9.48 | 8,012 | 75,954 | 2,104,911 | 2.1 M to 2.1 M (-0.38 %) |
Sep 18 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Sell | S | 9.22 | 44,207 | 407,589 | 2,112,923 | 2.2 M to 2.1 M (-2.05 %) |
May 17 2013 | TTPH | TETRAPHASE PHARMAC ... | Sutcliffe Joyce A. | Senior Vice Preside ... | Option Exercise | A | 7.94 | 70,913 | 563,049 | 70,913 | |
May 17 2013 | TTPH | TETRAPHASE PHARMAC ... | Horn Patrick Taylor | Chief Medical Offic ... | Option Exercise | A | 7.94 | 135,000 | 1,071,900 | 135,000 | |
May 17 2013 | TTPH | TETRAPHASE PHARMAC ... | Lubner David Charles | SVP and CFO | Option Exercise | A | 7.94 | 135,000 | 1,071,900 | 135,000 | |
May 17 2013 | TTPH | TETRAPHASE PHARMAC ... | Macdonald Guy | President and Chief ... | Option Exercise | A | 7.94 | 270,000 | 2,143,800 | 270,000 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 28,485,997 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 685,531 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 11,153,776 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 268,269 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 2,662,059 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 64,027 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 2,040,912 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Option Exercise | C | 0.00 | 49,088 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | P | 7.00 | 628,071 | 4,396,497 | 2,157,130 | 1.5 M to 2.2 M (+41.08 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | P | 7.00 | 14,786 | 103,502 | 51,576 | 36.8 K to 51.6 K (+40.19 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 982,275 | 0 | 1,529,059 | 546.8 K to 1.5 M (+179.65 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 23,639 | 0 | 36,790 | 13.2 K to 36.8 K (+179.75 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 384,613 | 0 | 546,784 | 162.2 K to 546.8 K (+237.17 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 9,250 | 0 | 13,151 | 3.9 K to 13.2 K (+237.12 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 91,795 | 0 | 162,171 | 70.4 K to 162.2 K (+130.44 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 2,208 | 0 | 3,901 | 1.7 K to 3.9 K (+130.42 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 70,376 | 0 | 70,376 | 0 to 70.4 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | CMEA VENTURES VI LP | 10% Owner | Buy | C | 0.00 | 1,693 | 0 | 1,693 | 0 to 1.7 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 19,544,924 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 9,626,604 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 11,422,045 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 2,726,088 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Option Exercise | C | 0.00 | 2,090,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | P | 7.00 | 491,824 | 3,442,768 | 1,165,786 | 674 K to 1.2 M (+72.98 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 673,962 | 0 | 673,962 | 0 to 674 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 331,953 | 0 | 891,887 | 559.9 K to 891.9 K (+59.28 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 393,863 | 0 | 559,934 | 166.1 K to 559.9 K (+237.17 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 94,003 | 0 | 166,071 | 72.1 K to 166.1 K (+130.44 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Flagship Ventures Fund 2004 L ... | 10% Owner | Buy | C | 0.00 | 72,068 | 0 | 72,068 | 0 to 72.1 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Option Exercise | C | 0.00 | 272,267 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Option Exercise | C | 0.00 | 234,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Option Exercise | C | 0.00 | 52,173 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Option Exercise | C | 0.00 | 40,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Buy | C | 0.00 | 9,388 | 0 | 52,569 | 43.2 K to 52.6 K (+21.74 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Buy | C | 0.00 | 8,068 | 0 | 43,181 | 35.1 K to 43.2 K (+22.98 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Buy | C | 0.00 | 1,800 | 0 | 35,113 | 33.3 K to 35.1 K (+5.40 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Trias Joaquim | 10% Owner | Buy | C | 0.00 | 1,379 | 0 | 33,313 | 31.9 K to 33.3 K (+4.32 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Cole Douglas G. | Director | Option Exercise | A | 7.07 | 20,000 | 141,400 | 20,000 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 2,917,152 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 8,556,982 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 2,761,571 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 9,101,517 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 6,193,019 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 3,096,509 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 2,132,517 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 1,043,478 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 521,739 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 521,739 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 400,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Option Exercise | C | 0.00 | 400,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | P | 7.00 | 121,428 | 849,996 | 540,592 | 419.2 K to 540.6 K (+28.97 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | P | 7.00 | 164,285 | 1,149,995 | 765,208 | 600.9 K to 765.2 K (+27.34 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 100,591 | 0 | 100,591 | 0 to 100.6 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 295,068 | 0 | 600,923 | 305.9 K to 600.9 K (+96.47 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 95,226 | 0 | 248,153 | 152.9 K to 248.2 K (+62.27 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 313,845 | 0 | 419,164 | 105.3 K to 419.2 K (+297.99 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 213,552 | 0 | 305,855 | 92.3 K to 305.9 K (+231.36 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 106,776 | 0 | 152,927 | 46.2 K to 152.9 K (+231.36 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 73,535 | 0 | 105,319 | 31.8 K to 105.3 K (+231.36 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 35,982 | 0 | 92,303 | 56.3 K to 92.3 K (+63.89 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 17,991 | 0 | 46,151 | 28.2 K to 46.2 K (+63.89 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 17,991 | 0 | 31,784 | 13.8 K to 31.8 K (+130.44 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 27,586 | 0 | 56,321 | 28.7 K to 56.3 K (+96.00 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 13,793 | 0 | 28,160 | 14.4 K to 28.2 K (+96.00 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | MEDIPHASE VENTURE PARTNERS II ... | 10% Owner | Buy | C | 0.00 | 13,793 | 0 | 13,793 | 0 to 13.8 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | EXCEL MEDICAL FUND LP | 10% Owner | Option Exercise | C | 0.00 | 28,199,144 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | EXCEL MEDICAL FUND LP | 10% Owner | Buy | P | 7.00 | 496,121 | 3,472,847 | 1,468,505 | 972.4 K to 1.5 M (+51.02 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | EXCEL MEDICAL FUND LP | 10% Owner | Buy | C | 0.00 | 972,384 | 0 | 972,384 | 0 to 972.4 K |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 27,226,760 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 11,422,045 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 2,726,086 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Option Exercise | C | 0.00 | 2,090,000 | 0 | 0 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | P | 7.00 | 681,012 | 4,767,084 | 2,190,145 | 1.5 M to 2.2 M (+45.13 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 938,853 | 0 | 1,509,133 | 570.3 K to 1.5 M (+164.63 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 393,863 | 0 | 570,280 | 176.4 K to 570.3 K (+223.26 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 94,003 | 0 | 176,417 | 82.4 K to 176.4 K (+114.06 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | Skyline Venture Partners Quali ... | 10% Owner | Buy | C | 0.00 | 72,069 | 0 | 82,414 | 10.3 K to 82.4 K (+696.66 %) |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | BOHLIN GAREN G | Director | Option Exercise | A | 7.07 | 20,000 | 141,400 | 20,000 | |
Mar 27 2013 | TTPH | TETRAPHASE PHARMAC ... | GAGE L PATRICK | Director | Option Exercise | A | 7.07 | 20,000 | 141,400 | 20,000 |